InVivoSIM anti-human CTLA-4 (Ipilimumab Biosimilar)
Bio X Cell
SKU / CAT#: SIM0004-5MG
$84300
usd$168.60/mg
InVivoSIM anti-human CTLA-4 (Ipilimumab Biosimilar)
Bio X Cell, LLCSKU / CAT#: SIM0004-5MG
MPN: SIM0004-5MG
$84300
usd$168.60/mg
Available
SHIPS Jul 17th
Available
SHIPS Jul 17th
SKU
Unit size / Options
Availability
Price
No products found
Description
InVivoSIM anti-human CTLA-4 (Ipilimumab Biosimilar), Clone: Ipilimumab, Size: 5 mg, Isotype: human IgG1, Applications: CTLA-4 neutralization, Flow Cytometry, ELISA, Western blot
InVivoSIM anti-human CTLA-4 (Ipilimumab Biosimilar), Clone: Ipilimumab, Size: 5 mg, Isotype: human IgG1, Applications: CTLA-4 neutralization, Flow Cytometry, ELISA, Western blot
Shipping & Handling
Shipped In
Cold Packs
Safety & Storage
Storage Temperature
Undiluted at 4°C in the dark
Safety Statement
For laboratory research and development purposes only.
Regulatory & Compliance
Specifications
COUNTRY OF ORIGIN
United States
APPLICATION
CTLA-4 neutralization, Flow Cytometry, ELISA, Western blot
GENE ID
https://www.ncbi.nlm.nih.gov/gene/1493
CLONE NUMBER
Ipilimumab
UNSPSC CODE
12352203*USAGE / SAFETY STATEMENT
For laboratory research and development purposes only.
CONCENTRATION
Lot specific,typically between 4-11 mg/ml
MWCO (kDa)
150 kDa
ANTIBODY TYPE
Biosimilar Antibody
HOST SPECIES
Human
ISOTYPE
IgG1
REACTIVITY SPECIES
Human
CLONALITY
Monoclonal
CONJUGATION/TAG
No
DILUTION
IP0070
IMMUNOGEN
Human CTLA-4
REACTIVITY/ANTIGEN
human CTLA-4
ANTIGEN
CTLA-4
HOST/ISOTYPE
human IgG1
RECOMMENDED ISOTYPE CTRL
BP0297
ANTIGEN MODIFICATION
No
MORPHOLOGIC FORM
Liquid
Questions & Answers (0)
Citations (0)
Shipping & Handling
Shipped In
Cold Packs
Safety & Storage
Storage Temperature
Undiluted at 4°C in the dark
Safety Statement
For laboratory research and development purposes only.
Regulatory & Compliance
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.Join Our List
Subscribe to the Scoop blog and get the latest updates on life in the lab.
Related Blog Articles
Related Blog Articles